Page last updated: 2024-09-24

totarol

Description

totarol: structure given in first source; isolated from the bark of Podocarpus nagi [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Podocarpusgenus[no description available]Podocarpaceae[no description available]
Podocarpus nagispecies[no description available]Podocarpaceae[no description available]

Cross-References

ID SourceID
PubMed CID92783
CHEMBL ID487602
CHEBI ID69241
SCHEMBL ID285501
MeSH IDM0210533

Synonyms (31)

Synonym
smr001562118
MLS002695958
SMP1_000215
totarol
(4bs)-trans-8,8-trimethyl-4b,5,6,7,8,8a,9,10-octahydro-1-isopropylphenanthren-2-ol, 98%
BCBCMAP01_000081
(+)-8,11,13-totara-trien-13-ol
LMPR0104070001
14-isopropylpodocarpa-8,11,13-trien-13-ol
CHEMBL487602
chebi:69241 ,
4b,5,6,7,8,8a,9,10-octahydro-4b,8,8-trimethyl-1-(1-methylethyl)-2-phenanthrenol
unii-67nh2854ww
nsc 299936
67nh2854ww ,
bdbm50392993
(4bs)-trans-8,8-trimethyl-4b,5,6,7,8,8a,9,10-octahydro-1-isopropylphenanthren-2-ol
totarol [inci]
(4as,10as)-7-hydroxy-8-isopropyl-1,1,4a-trimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene
podocarpa-8,11,13-trien-13-ol, 14-isopropy
(4bs-trans)-4b,5,6,7,8,8a,9,10-octahydro-4b,8,8-trimethyl-1-(1-isopropyl)-2-phenanthrenol
AKOS025296157
SCHEMBL285501
DTXSID9047752
NCGC00385162-01
(4bs,8as)-1-isopropyl-4b,8,8-trimethyl-
FS-9301
Q7828277
HY-N1136
(4bs,8as)-4b,8,8-trimethyl-1-(propan-2-yl)-4b,5,6,7,8,8a,9,10-octahydrophenanthren-2-ol
CS-0016424

Research Excerpts

Overview

ExcerptReference
"Totarol is a natural antimicrobial compound extracted from the heartwood of Podocarpus totara, a conifer native to New Zealand. "( Guo, M; Ma, S; Shi, C; Wang, C, 2017)
"Totarol is a naturally existing diterpenoid, which has the ability to restrain bacterial growth by perturbing the cell division."( Gajbhiye, A; Panda, D; Prasad, TS; Rapole, S; Ray, S; Reddy, PJ; Sathe, GJ; Srivastava, S, 2015)

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
diterpenoidAny terpenoid derived from a diterpene. The term includes compounds in which the C20 skeleton of the parent diterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency44.66840.631035.7641100.0000AID504339
glp-1 receptor, partialHomo sapiens (human)Potency10.00000.01846.806014.1254AID624417
TDP1 proteinHomo sapiens (human)Potency21.04410.000811.382244.6684AID686978; AID686979
Smad3Homo sapiens (human)Potency35.48130.00527.809829.0929AID588855
67.9K proteinVaccinia virusPotency15.84890.00018.4406100.0000AID720580
IDH1Homo sapiens (human)Potency29.09290.005210.865235.4813AID686970
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency32.64270.00419.984825.9290AID504444
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency50.11870.425612.059128.1838AID504891
gemininHomo sapiens (human)Potency9.20000.004611.374133.4983AID624296
TAR DNA-binding protein 43Homo sapiens (human)Potency14.12541.778316.208135.4813AID652104
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency56.23413.981146.7448112.2020AID720708
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Quinolone resistance protein NorAStaphylococcus aureusIC50 (µMol)15.00007.00008.50009.7000AID372221
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)AC503.79100.19503.667918.6960AID540270
heat shock protein 90, putativePlasmodium falciparum 3D7AC502.86300.19504.992098.5000AID540268
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (27)

Processvia Protein(s)Taxonomy
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (81)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID372223Inhibition of NorA efflux pump in Staphylococcus aureus isolate15 assessed as potentiation of oxacillin MIC2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID636080Selectivity index, ratio of IC50 for CHO cells to IC50 for chloroquine-resistant Plasmodium falciparum K12012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents.
AID336580Antifungal activity against Candida albicans ATCC 18804 up to 400 ug/ml after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID335713Antibacterial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID1226073Antiviral activity against oseltamivir-sensitive Influenza A virus (A/Hong Kong/8/68(H3N2)) infected in MDCK cells assessed as protection against virus-induced cytocidal effect at 20 uM after 48 hrs by CellTiter-Glo assay relative to control2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Phenolic diterpenoid derivatives as anti-influenza a virus agents.
AID336579Antifungal activity against Saccharomyces cerevisiae ATCC 7754 up to 400 ug/ml after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID692799Antibacterial activity against Bacillus subtilis 168 after 16 hrs2012ACS medicinal chemistry letters, Aug-28, Volume: 3, Issue:10
The Synthesis and Antimicrobial Activity of Heterocyclic Derivatives of Totarol.
AID372225Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as reduction in ethidium bromide MIC2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1120513Antimicrobial activity against Bacillus subtilis subsp. subtilis str. 168 after 18 hrs by macro-dilution method2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID636078Cytotoxicity against CHO cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents.
AID336566Antibacterial activity against penicillin-susceptible Staphylococcus aureus ATCC 12598 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID372221Inhibition of NorA efflux pump in Staphylococcus aureus K3092 assessed as inhibition of EtBr efflux2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID1120510Induction of transmembrane potential loss in Bacillus subtilis subsp. subtilis str. 168 at 1 times MIC pre-treated for 5 mins and measured 15 mins post dye addition by DiOC2 dye based flow cytometry2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID372228Antimicrobial activity against Staphylococcus aureus 1199B expressing NorA pump2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID336582Antifungal activity against Pityrosporum ovale ATCC 14521 up to 400 ug/ml after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID336567Antibacterial activity against penicillin-resistant Staphylococcus aureus ATCC 29247 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID1201468Antimicrobial activity against Escherichia coli2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID336569Antibacterial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID374687Antimicrobial activity against Staphylococcus aureus NCTC 8325-4 expressing NorA gene2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID336577Antibacterial activity against Enterobacter aerogenes ATCC 13048 up to 400 ug/ml after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID336568Antibacterial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID1201481Inhibition of FtsZ (unknown origin) assessed as reduction in enzyme GTPase activity2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID692800Inhibition of Bacillus subtilis FtsZ GTPase activity by enzyme-coupled assay2012ACS medicinal chemistry letters, Aug-28, Volume: 3, Issue:10
The Synthesis and Antimicrobial Activity of Heterocyclic Derivatives of Totarol.
AID335712Antibacterial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID1120502Protonophore activity in Bacillus subtilis subsp. subtilis str. 168 assessed as induction of rapid equlibration of delta-pH at 1 times MIC2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1201469Antimicrobial activity against Staphylococcus aureus2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID374692Antimicrobial activity against Staphylococcus aureus XU212 expressing tetK pump2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID636076Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by lactate dehydrogenase assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents.
AID372217Inhibition of MsrA efflux pump in Staphylococcus aureus RN4220 assessed as reduction in erythromycin MIC at 1 ug/ml2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID636077Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum K1 to IC50 for chloroquine-sensitive Plasmodium falciparum D102012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents.
AID336581Antifungal activity against Penicillium chrysogenum ATCC 10106 up to 400 ug/ml after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID636075Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs by lactate dehydrogenase assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents.
AID688450Allosteric modulation of gamma-aminobutyric acid receptor A alpha1beta2gamma2S expressed in Xenopus oocytes assessed as potentiation of GABA-mediated chloride current at 100 uM by voltage clamp analysis relative to control2011Journal of natural products, Aug-26, Volume: 74, Issue:8
Identification and characterization of GABA(A) receptor modulatory diterpenes from Biota orientalis that decrease locomotor activity in mice.
AID1226071Antiviral activity against oseltamivir/amantadine-resistant Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as protection against virus-induced cytocidal effect after 48 hrs by CellTiter-Glo assay2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Phenolic diterpenoid derivatives as anti-influenza a virus agents.
AID1201472Antimicrobial activity against Mycobacterium tuberculosis2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID374690Antimicrobial activity against Staphylococcus aureus K3092 overexpressing NorA gene2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID372222Inhibition of NorA efflux pump in methicillin-resistant Staphylococcus aureus assessed as reduction in methicillin MIC2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID1201473Inhibition of FtsZ in methicillin-resistant Staphylococcus aureus assessed as reduction in methicillin MIC (Rvb = 32 ug/ml)2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID636079Selectivity index, ratio of IC50 for CHO cells to IC50 for chloroquine-sensitive Plasmodium falciparum D102012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents.
AID336578Antibacterial activity against Escherichia coli ATCC 13048 up to 400 ug/ml after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID1120505Induction of membrane disruption in mouse C2C12 cells assessed as change in oxygen consumption rate2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID374694Inhibition of tetK efflux pump in Staphylococcus aureus XU212 assessed as reduction in tetracycline MIC at 1 ug/ml2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID1226075Antiviral activity against oseltamivir/amantadine-resistant Influenza A virus (A/Puerto Rico/8/1934(H1N1)) assessed as inhibition of viral infectivity in MDCK cells at 10 uM after 6 hrs by FITC conjugated anti-NP antibodies/DAPI staining-based confocal mi2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Phenolic diterpenoid derivatives as anti-influenza a virus agents.
AID1201474Binding affinity to Mycobacterium tuberculosis FtsZ2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID1120509Increase in bacterial membrane permeability in Bacillus subtilis subsp. subtilis str. 168 at 1 times MIC pre-treated for 5 mins and measured 30 mins post dye addition by propidium iodide dye based flow cytometry2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID372224Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID374689Antimicrobial activity against totarol-resistant Staphylococcus aureus K30902007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID372226Inhibition of NorA efflux pump in Staphylococcus aureus K3092 assessed as reduction in ethidium bromide MIC2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID374688Antimicrobial activity against NorA deficient Staphylococcus aureus K17582007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID374693Antimicrobial activity against Staphylococcus aureus ATCC 259232007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID1226072Cytotoxicity against MDCK cells assessed as reduction of cell viability2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Phenolic diterpenoid derivatives as anti-influenza a virus agents.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID336576Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 up to 400 ug/ml after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID688449Allosteric modulation of gamma-aminobutyric acid receptor A alpha1beta2gamma2S expressed in Xenopus oocytes assessed as potentiation of GABA-mediated chloride current at 10 uM by voltage clamp analysis relative to control2011Journal of natural products, Aug-26, Volume: 74, Issue:8
Identification and characterization of GABA(A) receptor modulatory diterpenes from Biota orientalis that decrease locomotor activity in mice.
AID372216Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as reduction in Norfloxacin MIC at 1 ug/ml2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID692801Inhibition of Bacillus subtilis FtsZ GTPase activity by enzyme-coupled assay in presence of 0.01% triton X-1002012ACS medicinal chemistry letters, Aug-28, Volume: 3, Issue:10
The Synthesis and Antimicrobial Activity of Heterocyclic Derivatives of Totarol.
AID374691Antimicrobial activity against Staphylococcus aureus RN4220 expressing MsrA protein2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID1201489Antimicrobial activity against Bacillus subtilis 1682015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID1120500Induction of membrane associated proteins mislocalization in Bacillus subtilis subsp. subtilis str. 168 assessed as reduction in GFP-MinD protein localization by fluorescence assay2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID372227Ratio of inhibition of CHO cells to IC50 for chloroquine-resistant Plasmodium falciparum2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID1120499Phospholipid-water partition coefficient, Kp of the compound2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1330856Inhibition of recombinant Mycobacterium tuberculosis FtsZ GTPase activity expressed in Escherichia coli assessed as inorganic phosphate release at 50 uM measured after 15 mins in presence of GTP using malachite green dye by fluorescence spectrophotometry 2016European journal of medicinal chemistry, Nov-10, Volume: 123FtsZ inhibition and redox modulation with one chemical scaffold: Potential use of dihydroquinolines against mycobacteria.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (14.58)18.2507
2000's17 (35.42)29.6817
2010's19 (39.58)24.3611
2020's5 (10.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (95.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Safety/Toxicity (1)

ArticleYear
Synthesis of totarol amino alcohol derivatives and their antiplasmodial activity and cytotoxicity.
Bioorganic & medicinal chemistry, Oct-01, Volume: 11, Issue: 20
2003
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (2)

ArticleYear
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology, Volume: 96, Issue: 5
2019
The synthesis and antibacterial activity of totarol derivatives. Part 1: modifications of ring-C and pro-drugs.
Bioorganic & medicinal chemistry, Volume: 7, Issue: 9
1999
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (1)

ArticleYear
Antibacterial activity of anacardic acid and totarol, alone and in combination with methicillin, against methicillin-resistant Staphylococcus aureus.
The Journal of applied bacteriology, Volume: 80, Issue: 4
1996
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]